KLRS Kalaris Therapeutics
Kalaris Therapeutics earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 11 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by KLRS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $6.2M bought by 1 insider
- $13K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Srinivas Akkaraju Director, +4 joint filersBuy$1.2M 244,300 shares at $4.83 +12% to stakeTraded May 20 Filed May 22
-
Brett R Hagen Chief Accounting OfficerSale$13K 1,915 shares at $6.72 100% of stakeTraded Mar 20 Filed Mar 23
-
Srinivas Akkaraju Director, +4 joint filersBuy$5M 479,847 shares at $10.42 +32% to stakeTraded Dec 18, 2025 Filed Feb 17
Also filed in the last 12 months, not counted as buying or selling: 3 other transactions and 1 stock grant.
SEC filings
Recent issuer filings from EDGAR, 23 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 424B3 | Filing Doc | ||
| 424B3 | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 1.01,3.02,8.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.